AbbVie · 1 day ago
Cost Analyst
Worcester, MA
Full-time
Onsite
Mid Level
$64K/yr - $122K/yr
3+ years expAbbVie is dedicated to discovering and delivering innovative medicines that address serious health issues. The Cost Accounting Analyst will support day-to-day project and cost accounting activities, interfacing with leadership across various functions to manage cost center budgets and perform month-end processes.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Support the day-to-day business activities which include project accounting, and account analysis and reporting, and setup/ update/ maintenance of inventory
Perform month-end processes which include but not limited to account reconciliations, booking monthly/quarterly journal entries, analyzing P&L variances
Partner with key stakeholders cross functionally to monitor, track, and manage cost center budgets
Help support key business reporting cycles (LBE, Updates, LRP, and Annual Plan)
Assist in the annual material standard setting process
Help develop and create Power BI reports required for business continuity
Qualification
Required
Bachelor's degree in Accounting, Finance, or Economics required
Minimum 3-5 year's related accounting and finance experience, preferably in manufacturing
Preferred
Experience in SAP preferred
Experience in Power BI is a plus
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
2026-01-17
MedCity News
2026-01-17
Company data provided by crunchbase